| 000 | 01591 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517183413.0 | ||
| 264 | 0 | _c20180521 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1865-8652 | ||
| 024 | 7 |
_a10.1007/s12325-017-0637-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFiorentzis, Miltiadis | |
| 245 | 0 | 0 |
_aMuscle Relaxants as a Risk Factor for Vis-à-tergo During Penetrating Keratoplasty: A Prospective Interventional Study. _h[electronic resource] |
| 260 |
_bAdvances in therapy _c12 2017 |
||
| 300 |
_a2674-2679 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrostanols _xtherapeutic use |
| 650 | 0 | 4 | _aAnesthesia, General |
| 650 | 0 | 4 |
_aAtracurium _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 |
_aIsoquinolines _xtherapeutic use |
| 650 | 0 | 4 |
_aKeratoplasty, Penetrating _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMivacurium |
| 650 | 0 | 4 |
_aNeuromuscular Nondepolarizing Agents _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aRocuronium |
| 650 | 0 | 4 | _aTonometry, Ocular |
| 700 | 1 | _aMorinello, Emanuela | |
| 700 | 1 | _aViestenz, Anja | |
| 700 | 1 | _aZuche, Hanna | |
| 700 | 1 | _aSeitz, Berthold | |
| 700 | 1 | _aViestenz, Arne | |
| 773 | 0 |
_tAdvances in therapy _gvol. 34 _gno. 12 _gp. 2674-2679 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-017-0637-1 _zAvailable from publisher's website |
| 999 |
_c27752798 _d27752798 |
||